Matrix metalloproteinase-3 mRNA: A promising peripheral blood marker for diagnosis of endometriosis

Gynecologic and Obstetric Investigation

Volumn 71, Issue 2, 2011, Pages 118-123

  De Sanctis, Paola ^a   Elmakky, Amira ^a   Farina, Antonio ^b   Caramelli, Elisabetta ^a   Seracchioli, Renato ^b   Mabrouk, Mohamed ^b   Mignemi, Giuseppe ^b   Venturoli, Stefano ^b   Villa, Gioia ^b   Guerrini, Manuela ^b   Manuzzi, Linda ^b   Montanari, Giulia ^b   Valvassori, Luisa ^a   Zucchini, Cinzia ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Endometriosis; Matrix metalloproteinase 3; Peripheral blood marker; Real time reverse transcription polymerase chain reaction; Vascular endothelial growth factor

Indexed keywords

BIOLOGICAL MARKER; GELATINASE B; MESSENGER RNA; STROMELYSIN; VASCULOTROPIN A;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; ENDOMETRIOSIS; FEMALE; HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; BIOLOGICAL MARKERS; ENDOMETRIOSIS; FEMALE; HUMANS; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79952442135     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000320752     Document Type: Article

References (38)

1. Goldman MB, Cramer DW: The epidemiology of endometriosis. Prog Clin Biol Res 1990; 323: 15-31.
2. Koninckx PR, Meuleman C, Demeyere S, Lesaffre E, Cornille FJ: Suggestive evidence that pelvic endometriosis is a progressive disease, whereas deeply infiltrating endometriosis is associated with pelvic pain. Fertil Steril 1991; 55: 759-765.
3. Sampson JA: Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue to the peritoneal cavity. Am J Obstet Gynecol 1927; 14: 422-425.
4. Kitawaki J, Kado N, Ishihara H, Koshiba H, Kitaoka Y, Honjo H: Endometriosis: the pathophysiology as an estrogen-dependent disease. J Steroid Biochem Mol Biol 2002; 83: 149-155. (Pubitemid 37040651)
5. Gaetje R, Holtrich U, Engels K, Kissler S, Rody A, Karn T, Kaufmann M: Differential expression of claudins in human endometrium and endometriosis. Gynecol Endocrinol 2008; 24: 442-449.
6. Gaetje R, Rody A, Kissler S, Kaufmann M, Ahr A: Integrin expression in eutopic and ectopic endometrium. Zentralbl Gynakol 2006; 128: 135-137. (Pubitemid 43944314)
7. Gaetje R, Kotzian S, Herrmann G, Baumann R, Starzinski-Powitz A: Nonmalignant epithelial cells, potentially invasive in human endometriosis, lack the tumor suppressor molecule E-cadherin. Am J Pathol 1997; 150: 461-467. (Pubitemid 27073776)
8. Gaetje R, Holtrich U, Engels K, Kourtis K, Cikrit E, Kissler S, Rody A, Karn T, Kaufmann M: Expression of membrane-type 5 matrix metalloproteinase in human endometrium and endometriosis. Gynecol Endocrinol 2007; 23: 567-573. (Pubitemid 47613727)
9. Kita Y, Fukagawa T, Mimori K, Kosaka Y, Ishikawa K, Aikou T, Natsugoe S, Sasako M, Mori M: Expression of uPAR mRNA in peripheral blood is a favourite marker for metastasis in gastric cancer cases. Br J Cancer 2009; 100: 153-159.
10. Shen C, Hu L, Xia L, Li Y: The detection of circulating tumor cells of breast cancer patients by using multimarker (Survivin, hTERT and hMAM) quantitative real-time PCR. Clin Biochem 2009; 42: 194-200.
11. Donnez J, Smoes P, Gillerot S, Casanas-Roux F, Nisolle M: Vascular endothelial growth factor (VEGF) in endometriosis. Hum Reprod 1998; 13: 1686-1690. (Pubitemid 28310515)
12. McLaren J: Vascular endothelial growth factor and endometriotic angiogenesis. Hum Reprod Update 2000; 6: 45-55. (Pubitemid 30099342)
13. Taylor RN, Lebovic DI, Mueller MD: Angiogenic factors in endometriosis. Ann NY Acad Sci 2002; 955: 89-100. (Pubitemid 34271066)
14. Groothuis PG, Nap AW, Winterhager E, Grummer R: Vascular development in endometriosis. Angiogenesis 2005; 8: 147-156. (Pubitemid 41712844)
15. Tan XJ, Lang JH, Liu DY, Shen K, Leng JH, Zhu L: Expression of vascular endothelial growth factor and thrombospondin-1 mRNA in patients with endometriosis. Fertil Steril 2002; 78: 148-153. (Pubitemid 34722685)
16. Takehara M, Ueda M, Yamashita Y, Terai Y, Hung YC, Ueki M: Vascular endothelial growth factor A and C gene expression in endometriosis. Hum Pathol 2004; 35: 1369-1375. (Pubitemid 39601577)
17. Gilabert-Estellés J, Ramón LA, Espana F, Gilabert J, Vila V, Réganon E, Castelló R, Chirivella M and Estellés A: Expression of angiogenic factors in endometriosis: relationship to fibrinolytic and metalloproteinase systems. Hum Reprod 2007; 22: 2120-2127. (Pubitemid 47241856)
18. Di Carlo C, Bonifacio M, Tommaselli GA, Bifulco G, Guerra G, Nappi C: Metalloproteinases, vascular endothelial growth factor, and angiopoietin 1 and 2 in eutopic and ectopic endometrium. Fertil Steril 2009; 91: 2315-2323.
19. Machado DE, Abrao MS, Berardo PT, Takiya CM, Nasciutti LE: Vascular density and distribution of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 (Flk-1) are significantly higher in patients with deeply infiltrating endometriosis affecting the rectum. Fertil Steril 2008; 90: 148-155. (Pubitemid 351885185)
20. Fasciani A, D'Ambrogio G, Bocci G, Monti M, Genazzani AR, Artini PG: High concentrations of the vascular endothelial growth factor and interleukin-8 in ovarian endometriomata. Mol Hum Reprod 2000; 6: 50-54. (Pubitemid 30043588)
21. Matalliotakis IM, Goumenou AG, Koumantakis GE, Neonaki MA, Koumantakis EE, Dionyssopoulou E, Athanassakis I, Vassiliadis S: Serum concentrations of growth factors in women with and without endometriosis: the action of anti-endometriosis medicines. Int Immunopharmacol 2003; 3: 81-89. (Pubitemid 36106453)
22. Oliveira VA, Abreu LG, Ferriani RA, Reis RM, Moura MD: Vascular endothelial growth factor in the plasma, follicular fluid and granulosa cells of women with endometriosis submitted to in vitro fertilization - a pilot study. Gynecol Endocrinol 2005; 20: 284-288. (Pubitemid 40897395)
23. Xavier P, Belo L, Beires J, Rebelo I, Martinezde- Oliveira J, Lunet N, Barros H: Serum levels of VEGF and TNF-alpha and their association with C-reactive protein in patients with endometriosis. Arch Gynecol Obstet 2006; 273: 227-231. (Pubitemid 43004695)
24. Gagné D, Pagé M, Robitaille G, Hugo P, Gosselin D: Levels of vascular endothelial growth factor (VEGF) in serum of patients with endometriosis. Hum Reprod 2003; 18: 1674-1680. (Pubitemid 36958049)
25. Othman Eel-D, Hornung D, Salem HT, Khalifa EA, El-Metwally TH, Al-Hendy A: Serum cytokines as biomarkers for nonsurgical prediction of endometriosis. Eur J Obstet Gynecol Reprod Biol Appl 2008; 137: 240-246. (Pubitemid 351423457)
26. Zhou HE, Nothnick WB: The relevancy of the matrix metalloproteinase system to the pathophysiology of endometriosis. Front Biosci 2005; 10: 569-575.
27. Osteen KG, Bruner KL, Sharpe-Timms KL: Steroid and growth factor regulation of matrix metalloproteinase expression and endometriosis. Semin Reprod Endocrinol 1996; 14: 247-255. (Pubitemid 126450924)
28. Sillem M, Prifti S, Koch A, Neher M, Jauckus J, Runnebaum B: Regulation of matrix metalloproteinases and their inhibitors in uterine endometrial cells of patients with and without endometriosis. Eur J Obstet Gynecol Reprod Biol 2001; 95: 167-174. (Pubitemid 32297710)
29. Gilabert-Estellés J, Estellés A, Gilabert J, Castelló R, Espana F, Falcó C, Romeu A, Chirivella M, Zorio E, Aznar J: Expression of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis. Hum Reprod 2003; 18: 1516-1522. (Pubitemid 36840963)
30. Ramón L, Gilabert-Estellés J, Castelló R, Gilabert J, Espana F, Romeu A, Chirivella M, Aznar J, Estellés A: mRNA quantitative analysis of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis using real-time reverse transcription-PCR assay. Hum Reprod 2005; 20: 272-278.
31. Chung HW, Wen Y, Chun SH, Nezhat C, Woo BH, Lake Polan M: Matrix metalloproteinase- 9 and tissue inhibitor of metalloproteinase- 3 mRNA expression in ectopic and eutopic endometrium in women with endometriosis: a rationale for endometriotic invasiveness. Fertil Steril 2001; 75: 152-159. (Pubitemid 32041238)
32. Li Y, Lang JH: Expressions of matrix metalloproteinase- 9 and tissue inhibitor of metalloproteinase- 1 mRNA in endometriosis. Zhonghua Fu Chan Ke Za Zhi 2006; 41: 30-33.
33. Salata IM, Stojanovic N, Cajdler-£uba A, Lewandowski KC, Lewiñski A: Gelatinase A (MMP-2), gelatinase B (MMP-9) and their inhibitors (TIMP 1, TIMP-2) in serum of women with endometriosis: significant correlation between MMP-2, MMP-9 and their inhibitors without difference in levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in relation to the severity of endometriosis. Gynecol Endocrinol 2008; 24: 326-330. (Pubitemid 351918000)
34. Agic A, Xu H, Rehbein M, Wolfler MM, Ebert AD, Hornung D: Cognate chemokine receptor 1 messenger ribonucleic acid expression in peripheral blood as a diagnostic test for endometriosis. Fertil Steril 2007; 87: 982-984. (Pubitemid 46550419)
35. Agic A, Djalali S, Wolfler MM, Halis G, Diedrich K, Hornung D: Combination of CCR1 mRNA, MCP1, and CA125 measurements in peripheral blood as a diagnostic test for endometriosis. Reprod Sci 2008; 15: 906-911.
36. Riedel F, Zaiss I, Herzog D, Götte K, Naim R, Hörmann K: Serum levels of interleukin-6 in patients with primary head and neck squamous cell carcinoma. Anticancer Res 2005; 25: 2761-2765.
37. Hayasaka A, Suzuki N, Fujimoto N, Iwama S, Fukuyama E, Kanda Y, Saisho H: Elevated plasma levels of matrix metalloproteinase-9 (92-kd type IV collagenase/gelatinase B) in hepatocellular carcinoma. Hepatology 1996; 24: 1058-1062. (Pubitemid 26365903)
38. Laack E, Scheffler A, Burkholder I, Boeters I, Andritzky B, Schuch G, Görn M, Vohwinkel G, Edler L, Fiedler W, Hossfeld DK: Pretreatment vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 (MMP-9) serum levels in patients with metastatic non-small cell lung cancer (NSCLC). Lung Cancer 2005; 50: 51-58. (Pubitemid 41297469)